Meeting the rising demand for radiotherapy: perspectives from our founding doctors

Return to the latest news

Did you know that cancer incidence in Europe is rising faster than ever, putting immense pressure on healthcare systems to keep up?

In this video, our founding doctors and co-chairpersons of Board of Directors – Dr. Guglielmo Brayda di Soleto, Dr. Sandra Röddiger and Dr. Ralf Kurek – share their insights on some key topics related to the challenges and solutions in enhancing patient access to high quality cancer treatments in Europe.

Please enable cookies to access and view the video.

Related Articles

PPP in Nuclear Medicine

Medipass | Ergéa Hospital Partnerships launches a new partnership with the IRCCS “Fondazione G. Pascale” National Cancer Institute for Nuclear Medicine

Hospital Partnership - the new B2B brand of Ergéa Italia

Hospital Partnership: a new brand to enhance Ergéa Group’s B2B offer

Hospital Partnership Mestre

Medipass | Ergéa Group renews its Managed Equipment Services partnership at Ospedale dell’Angelo in Mestre

David Rolfe, CEO at Ergéa Group

Ergéa Group appoints David Rolfe as new Group Chief Executive Officer

Camion che trasporta una risonanza magnetica

Medipass | Ergéa Group acquires IML – International Medical

Sala di chirurgia cardiovascolare

Servitech S.r.l. joins Medipass | Ergéa Group

Risonanza magnetica 3 tesla presso il centro Vitalis

Medipass | Ergéa Group expands in the Emilia-Romagna region with acquisition of two medical centres

La Fenice Centro Medico Diagnostico

Medipass | Ergéa Group acquires two medical centres in the Marche region in Italy

Acceleratore lineare

Meeting the rising demand for radiotherapy: perspectives from our founding doctors